Lazertinib/Pemetrexed/Carboplatin After Osimertinib Failure in NSCLC With Brain Metastases
Clinical trial NCT05477615 · UNKNOWN
Trial details
- NCT number
- NCT05477615
- Sponsor
- Jin Hyoung Kang
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2023-06-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.